Combat Effectiveness Boosted Fivefold! New "Smart" Immune Cells Precisely Target and Eliminate Cancer Cells
Release time:
2025-04-18
Imagine if immune cells in the human body could transform into "smart missiles," relentlessly tracking and destroying cancer cells without harming healthy tissue—this would revolutionize cancer treatment. A groundbreaking announcement from the USC Viterbi School of Engineering reveals the arrival of "EchoBack CAR T cells", a new breed of "thinking" immune warriors propelling targeted cancer therapy into a 2.0 era!
From "Blitzkrieg" to "Prolonged Warfare": Immune Cells Upgrade Combat Tactics
While traditional CAR T-cell therapies have shown success against blood cancers, their activity often fades within 24 hours. In contrast, USC’s EchoBack cells are "endurance champions": a single ultrasound activation keeps them battle-ready for five days, continuously releasing anti-cancer munitions.
"With first-generation cells, patients might need daily hospital visits. But the new cells could reduce treatment frequency to biweekly sessions, or even less," explains Longwei Liu, Assistant Professor at USC Viterbi.
In prostate cancer and glioblastoma mouse models, two rounds of ultrasound stimulation boosted tumor clearance efficiency by 300% compared to conventional therapies. Remarkably, as cancer cells counterattack, these "smart hunters" grow fiercer, producing more lethal molecules.
Precision Navigation + Self-Destruct Protocol: Dual Safeguards for Safety
The breakthrough lies in an "ultrasound switch" design:
Targeted Activation: A 10-minute, non-invasive ultrasound pulse pinpoints tumor regions, acting like GPS for CAR T cells.
Intelligent Recognition: Activated cells deploy "molecular probes" to track cancer cells like heat-seeking missiles.
Safe Self-Destruction: Anti-cancer receptors degrade automatically post-mission, preventing collateral damage.
"This is a true breakthrough," adds Yingxiao Wang, Chair of USC’s Alfred E. Mann Department of Biomedical Engineering. "It paves the way for ultrasound-controlled CAR T therapies to become clinically viable."
From Lab to Clinic: A New Era in Cancer Treatment
The technology has shown promise across multiple solid tumor models. The team is advancing clinical trials and aims to adapt this modular platform for other cancers, such as breast cancer and retinoblastoma.
Published in Cell, this study not only redefines CAR T therapy but also expands the boundaries of precision medicine. If successfully translated, this "perpetual-motion-like" smart immunotherapy could slash treatment frequency and side effects, offering hope for advanced solid tumor patients. As the researchers declare: "This isn’t just an upgrade—it’s a complete paradigm shift in cancer treatment."
Latest developments
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.
On the morning of May 17, 2025, an immersive exploration into life sciences and cryomedicine concluded successfully at Jinan Yinfeng Biological Science Park. Hosted by the Shandong Yinfeng Life Science Research Institute, this event offered members a firsthand look into the research base through activities such as ultra-low temperature cryotherapy experiences, brainwave signal acquisition system trials, and expert panel discussions. Participants witnessed the infinite possibilities that cryogenic technology and life sciences hold for humanity.
The international academic platform ScholarGPS recently announced its global lists of Highly Ranked Scholars - Lifetime and Highly Ranked Scholars - Prior 5 Years, recognizing the top 0.05% of scholars across various disciplines. Among the selected Chinese scholars are national-level talents, leading figures in specialized fields, and seasoned academics dedicated to long-term research.
In January 2025, members of the Yinfeng cryomedicine team actively participated in the "Sino-French Aerial Emergency Medical Rescue Training" and obtained certification. This signifies a further enhancement of the team's professional capabilities in the field of international emergency medical rescue.
Brands are an important symbol of high-quality development. Under the drive of strategies such as Brand Strong Province and Good Products Shandong, Shandong brands have risen to prominence. Particularly in recent years, Shandong brands have focused on new quality productivity, using "new" to enhance quality, achieving remarkable results in high-quality development.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
